These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33132380)

  • 21. [Use of water-soluble beta-cyclodextrin derivatives as carriers of anti-inflammatory drug biphenylylacetic acid in rectal delivery].
    Arima H; Kondo T; Irie T; Hirayama F; Uekama K; Miyaji T; Inoue Y
    Yakugaku Zasshi; 1992 Jan; 112(1):65-72. PubMed ID: 1578346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement of some physicochemical properties of arundic acid, (R)-(-)-2-propyloctanonic acid, by complexation with hydrophilic cyclodextrins.
    Miyamoto Y; Nakahara M; Motoyama K; Ishiguro T; Oda Y; Yamanoi T; Okamoto I; Yagi A; Nishimura H; Hirayama F; Uekama K; Arima H
    Int J Pharm; 2011 Jul; 413(1-2):63-72. PubMed ID: 21540089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Some pharmaceutical and inclusion properties of 2-hydroxybutyl-β-cyclodextrin derivative.
    Ishiguro T; Morishita E; Iohara D; Hirayama F; Wada K; Motoyama K; Arima H; Uekama K
    Int J Pharm; 2011 Oct; 419(1-2):161-9. PubMed ID: 21839823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of the antiinflammatory effect of ethyl 4-biphenylyl acetate in ointment by beta-cyclodextrin derivatives: increased absorption and localized activation of the prodrug in rats.
    Arima H; Adachi H; Irie T; Uekama K; Pitha J
    Pharm Res; 1990 Nov; 7(11):1152-6. PubMed ID: 2293214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solid-state 13C nuclear magnetic resonance spectroscopic study on amorphous solid complexes of tolbutamide with 2-hydroxypropyl-alpha- and -beta-cyclodextrins.
    Kimura K; Hirayama F; Arima H; Uekama K
    Pharm Res; 1999 Nov; 16(11):1729-34. PubMed ID: 10571279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inclusion complex of 3,9-bis(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) with heptakis(2,6-di-O-methyl)-beta-cyclodextrin: interaction and dissolution properties.
    Yamada T; Imai T; Ouchi K; Otagiri M; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1264-9. PubMed ID: 10993223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclodextrin-catalyzed deacetylation of spironolactone is pH and cyclodextrin dependent.
    Jarho P; Vander Velde D; Stella VJ
    J Pharm Sci; 2000 Feb; 89(2):241-9. PubMed ID: 10688753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solid dispersion of hydroxypropyl beta-cyclodextrin and ketorolac: enhancement of in-vitro dissolution rates, improvement in anti-inflammatory activity and reduction in ulcerogenicity in rats.
    Nagarsenker MS; Meshram RN; Ramprakash G
    J Pharm Pharmacol; 2000 Aug; 52(8):949-56. PubMed ID: 11007065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Novel approach of cyclodextrin-based pharmaceutical formulation].
    Uekama K
    Yakugaku Zasshi; 2012; 132(1):85-105. PubMed ID: 22214584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmaceutical and physical properties of paclitaxel (Taxol) complexes with cyclodextrins.
    Sharma US; Balasubramanian SV; Straubinger RM
    J Pharm Sci; 1995 Oct; 84(10):1223-30. PubMed ID: 8801338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of naproxen with ionic cyclodextrins in aqueous solution and in the solid state.
    Mura P; Furlanetto S; Cirri M; Maestrelli F; Corti G; Pinzauti S
    J Pharm Biomed Anal; 2005 Apr; 37(5):987-94. PubMed ID: 15862677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inclusion complexation of p-hydroxybenzoic acid esters with 2-hydroxypropyl-beta-cyclodextrins. On changes in solubility and antimicrobial activity.
    Matsuda H; Ito K; Sato Y; Yoshizawa D; Tanaka M; Taki A; Sumiyoshi H; Utsuki T; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 1993 Aug; 41(8):1448-52. PubMed ID: 8403092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the complexes of furosemide with 2-hydroxypropyl-beta-cyclodextrin and sulfobutyl ether-7-beta-cyclodextrin.
    Spamer E; Müller DG; Wessels PL; Venter JP
    Eur J Pharm Sci; 2002 Sep; 16(4-5):247-53. PubMed ID: 12208454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melarsoprol-cyclodextrins inclusion complexes.
    Gibaud S; Zirar SB; Mutzenhardt P; Fries I; Astier A
    Int J Pharm; 2005 Dec; 306(1-2):107-21. PubMed ID: 16253447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dramatic improvement of the solubility of pseudolaric acid B by cyclodextrin complexation: preparation, characterization and validation.
    Chi L; Liu R; Guo T; Wang M; Liao Z; Wu L; Li H; Wu D; Zhang J
    Int J Pharm; 2015 Feb; 479(2):349-56. PubMed ID: 25575474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced antiproliferative activity of the new anticancer candidate LPSF/AC04 in cyclodextrin inclusion complexes encapsulated into liposomes.
    Mendonça EA; Lira MC; Rabello MM; Cavalcanti IM; Galdino SL; Pitta IR; Lima Mdo C; Pitta MG; Hernandes MZ; Santos-Magalhães NS
    AAPS PharmSciTech; 2012 Dec; 13(4):1355-66. PubMed ID: 23054982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
    Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
    Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hygroscopicity, phase solubility and dissolution of various substituted sulfobutylether beta-cyclodextrins (SBE) and danazol-SBE inclusion complexes.
    Jain AC; Adeyeye MC
    Int J Pharm; 2001 Jan; 212(2):177-86. PubMed ID: 11165075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced rectal absorption and reduced local irritation of the anti-inflammatory drug ethyl 4-biphenylylacetate in rats by complexation with water-soluble beta-cyclodextrin derivatives and formulation as oleaginous suppository.
    Arima H; Kondo T; Irie T; Uekama K
    J Pharm Sci; 1992 Nov; 81(11):1119-25. PubMed ID: 1447717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physicochemical properties of inclusion complexes of highly soluble β-cyclodextrins with highly hydrophobic testosterone propionate.
    Celia C; Scala A; Stancanelli R; Surdo E; Paolino D; Grattoni A; Micale N; Crupi V; Majolino D; Fresta M; Tommasini S; Venuti V; Ventura CA
    Int J Pharm; 2017 Dec; 534(1-2):316-324. PubMed ID: 29042336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.